Uterine cancer is currently the only cancer type not covered by the World Trade Center (WTC) Health Program.
The World Trade Center (WTC) Health Program announced it is considering adding uterine cancer to the List of WTC-Related Health Conditions according to a recently published Notice of Proposed Rulemaking. Uterine cancer is currently the only cancer type not covered by the WTC Health Program.1
This notice proposes every type of uterine cancer, including endometrial cancer, be added to the 9/11-related health conditions list. By including uterine cancer in the List, it would grant the WTC Health Program the ability to offer treatment to members who have 9/11-related uterine cancers.
“We know that WTC Health Program members continue to face health challenges that stem from their exposures on or in the months after 9/11,” said John Howard, MD, administrator of the WTC Health Program and director of the National Institute for Occupational Safety and Health. “The proposed rule published today in the Federal Register is the next step toward ensuring women who are enrolled in the WTC Health Program have access to the cancer care and treatment they need if their uterine cancer is related to their 9/11 exposures.”
For more information on the WTC Health Program, visit www. CDC.gov/WTC.
Reference
1. The world trade center health program proposes rulemaking to add uterine cancer to the list of world trade center-related conditions. NIOSH. CDC . Published May 10, 2022. Accessed June 3, 2022. https://www.cdc.gov/niosh/updates/upd-05-10-22.html
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
2 Commerce Drive
Cranbury, NJ 08512